University of Michigan Dermatology Research-Ann Arbor
Primary Coordinator Lisa Pilley, PA-C 734-936-4075
- Indication: Psoriasis and Psoriatic Arthritis
- Enrollment Status: Open
- Protocol: PS0039 “Be Unique”
- Drug: bimekizumab
- Sponsor: UCB
- Description: A Phase 3b Exploratory Multicenter Open-Label Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis With and Without Psoriatic Arthritis.